시장보고서
상품코드
2051123

예방 의료 기술 및 서비스 시장 : 서비스 유형별, 기술 유형별, 최종사용자별, 지역별

Preventive Healthcare Technologies And Services Market, By Service Type, By Technology Type, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,760,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,516,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,024,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

예방 의료 기술 및 서비스 시장은 2026년에 3,386억 1,000만 달러로 추정되며, 2033년까지 7,030억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 11.0%로 성장할 것으로 전망됩니다.

보고서 범위 보고서 상세
기준 연도: 2025년 2026년 시장 규모: 3,386억 1,000만 달러
과거 데이터 기간: 2020-2024년 예측 기간: 2026-2033년
2026년부터 2033년까지 예측 기간 CAGR: 11.00% 2033년 금액 예측: 7,030억 달러

세계 예방 의료 기술 및 서비스 시장은 최근 몇 년 동안 괄목할 만한 성장을 거듭하고 있습니다. 예방의학은 질병, 건강상태의 악화 또는 부상을 예방하고 건강을 증진시키는 것을 목적으로 합니다. 기술의 발전과 인구의 건강관리에 대한 관심이 높아짐에 따라 예방의료의 범위가 확대되고 있습니다. 영상 진단, 첨단 바이오마커, 유전학 등 다양한 기술을 통해 질병의 조기 발견과 위험도 평가가 가능해졌습니다. 또한, 디지털 헬스 솔루션의 보급으로 원격 모니터링이 가능해져 예방 서비스에 대한 접근이 쉬워지고 있습니다. 전 세계적으로 만성질환의 유병률이 증가함에 따라 예방적 개입에 대한 수요가 급증하고 있습니다. 이는 혁신적인 예방 의료 모델과 대책 개발을 위한 투자를 촉진하고 있습니다. 예방에 대한 관심이 높아짐에 따라 향후 몇 년 동안 시장은 크게 성장할 것으로 예상됩니다.

시장 역학

생활습관병 발생률의 증가, 만성질환에 취약한 고령 인구의 증가, 치료에 따른 의료비 증가가 예방 의료 기술 및 서비스에 대한 수요를 견인하고 있습니다. 국민 건강을 위한 다양한 정부 프로그램도 이러한 솔루션 도입에 힘을 실어주고 있습니다. 그러나 고도의 예방 기술 및 서비스 도입을 위한 막대한 투자가 필요하다는 점이 걸림돌로 작용하고 있습니다. 저렴한 가격의 예방 솔루션을 개발하는 것은 시장 참여자들에게 기회가 될 수 있습니다. 또한, 인공지능과 같은 첨단 기술을 통합하는 것은 예방의학에 혁명을 가져올 수 있는 잠재력을 가지고 있습니다.

본 조사의 주요 특징

  • 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
  • 본 조사에서는 다음과 같은 매개변수를 바탕으로 세계 예방 의료 기술 및 서비스 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
  • 주요 기업으로는 Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., McKesson Corporation이 포함됩니다.
  • 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
  • 세계 예방 의료 기술 및 서비스 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 예방 의료 기술 및 서비스 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있을 것입니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 예방 의료 기술 및 서비스 시장 : 서비스 유형별, 2021-2033년

제5장 세계의 예방 의료 기술 및 서비스 시장 : 기술 유형별, 2021-2033년

제6장 세계의 예방 의료 기술 및 서비스 시장 : 최종사용자별, 2021-2033년

제7장 세계의 예방 의료 기술 및 서비스 시장 : 지역별, 2021-2033년

제8장 경쟁 구도

제9장 애널리스트의 견해

제10장 참고문헌 및 조사 방법

KSM 26.06.16

Preventive Healthcare Technologies And Services Market is estimated to be valued at USD 338.61 Bn in 2026 and is expected to reach USD 703 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 338.61 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.00% 2033 Value Projection: USD 703 Bn

The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global preventive healthcare technologies and services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Market Segmentation

  • By Service Type (Revenue, USD Bn, 2021 - 2033)
  • Diagnostic Services
  • Wellness & Health Assessment Services
  • Telemedicine Services
  • Pharmacy Services
  • Others
  • By Technology Type (Revenue, USD Bn, 2021 - 2033)
  • Telemedicine
  • mHealth
  • Health Information Technology
  • Wearable Devices
  • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Healthcare Providers
  • Healthcare Payers
  • Others
  • By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • Healthlane
  • Abbott
  • GSK plc
  • Myriad Genetics
  • Omron Healthcare Inc.
  • Quest Diagnostics
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Omnicell
  • Novx Systems, Corp.
  • U-Systems, Ltd.
  • Viatronix, Inc.
  • Scripto LLC
  • Lifecom, Inc.
  • Dilon Medical Technologies, Inc.
  • McKesson Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Technology Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Brand and Pricing Analysis
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Preventive Healthcare Technologies And Services Market, By Service Type, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostic Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Wellness & Health Assessment Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Telemedicine Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Pharmacy Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Preventive Healthcare Technologies And Services Market, By Technology Type, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Telemedicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • mHealth
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Health Information Technology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Wearable Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Preventive Healthcare Technologies And Services Market, By End User, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Healthcare Providers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Healthcare Payers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Preventive Healthcare Technologies And Services Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Healthlane
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Myriad Genetics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Omron Healthcare Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Quest Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Omnicell
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novx Systems, Corp.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • U-Systems, Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Viatronix, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Scripto LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lifecom, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dilon Medical Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • McKesson Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
문의하기